Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety
Status:
Active, not recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is exploratorily evaluate the effect on gastric mucosal tissue and
the safety of long-term administration (260 weeks: 5 years) of vonoprazan 10 mg or 20 mg in
patients receiving maintenance treatment after healed erosive esophagitis (EE), and the
curative effect of vonoprazan 20 mg versus lansoprazole in patients with EE.